Seqens Seqens

X

Find Radio Compass News for Prestwick3_000358

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
63
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

https://recalls-rappels.canada.ca/en/alert-recall/jamp-cephalexin-suspension-suspendability-out-specification

HEALTH CANADA
22 Mar 2024

https://www.centrient.com/media/ginkgo-bioworks-and-centrient-pharmaceuticals-announce-expansion-partnership-following

PRESS RELEASE
25 May 2023

https://health.economictimes.indiatimes.com/news/pharma/chinas-covid-surge-corona-drug-associated-apis-get-costlier/96509567

ECONOMICTIMES
27 Dec 2022

https://www.centrient.com/media/25-years-sustainable-cephalexin-production-centrient-spain-one-biggest-first-generation

PRESS RELEASE
11 Nov 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf

FDA
24 Feb 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-13-2021-1610520934.pdf

FDA
13 Jan 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-16-2020-1600259824.pdf

FDA
16 Sep 2020

https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-teva-canadas-cephalexin-1598867684.pdf

HEALTH CANADA
21 Aug 2020

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-13-2019-1573625418.pdf

FDA
13 Nov 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210221

FDA
29 Mar 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-6-2019-1549474146.pdf

FDA
06 Feb 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-23-2019-1548227584.pdf

FDA
23 Jan 2019

http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=suspenso-lote-de-antibiotico-produzido-pelo-laboratorio-teuto&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=2908727&_101_INSTANCE_FXrpx9qY7FbU_type=content

ANVISA
19 Jul 2016

http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/proibido+uso+de+lote+de+cefalexina+do+laboratorio+teuto

ANVISA
01 Feb 2016

http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/suspenso+lote+do+medicamento+cefalexina+do+laboratorio+teuto+brasileiro

ANVISA
26 Nov 2015

http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

Eric Palmer FIERCE PHARMA MFG
02 May 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY